Clinical Trial Update: A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United Kingdom [Phase 3]

View source ↗

Summary

Phase 3 clinical trial in the United Kingdom evaluating treatment for open angle glaucoma or ocular hypertension; study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Ocular Hypertension, Open Angle Glaucoma | Phase 3 | Status: COMPLETED